PRELIMINARY RESULTS ANNOUNCEMENT for the year ended 31 December 2011
27th March 2012 - 7:31 amImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, is pleased to announce its preliminary audited results for the year ended 31 December 2011.